The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cancer patients’ views on clinical research in Brazil: Concerns, knowledge, and misconceptions—A national survey.
 
Heloisa Resende
Speakers' Bureau - Libbs
Research Funding - Libbs
Travel, Accommodations, Expenses - pfizer
 
Raphael Oliveira
No Relationships to Disclose
 
Poliana Signorini
Speakers' Bureau - AstraZeneca; Lilly; Novartis
Travel, Accommodations, Expenses - AstraZeneca
 
Cristina Sampaio
No Relationships to Disclose
 
Sabina Aleixo
No Relationships to Disclose
 
Lilian Arruda De Rêgo Barros
No Relationships to Disclose
 
Jose Bines
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Knight Pharmaceuticals; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; MSD; Pfizer; Roche
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Roche
 
Graziela Dal Molin
No Relationships to Disclose
 
Giuliano Santos Borges
No Relationships to Disclose
 
Eldsamira Mascarenhas
Consulting or Advisory Role - AstraZeneca; Janssen Oncology; Pfizer; Roche
Travel, Accommodations, Expenses - Daichii; Janssen Oncology; Roche
 
Cristiano Souza
No Relationships to Disclose
 
ana Caroline Gelatti
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Janssen Oncology; MSD Oncology; Pfizer; Roche
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Janssen Oncology; MSD Oncology; Pfizer
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Janssen Oncology; MSD Oncology; Pfizer; Takeda
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Janssen Oncology; MSD Oncology; Pfizer
 
Fernanda Damian
Travel, Accommodations, Expenses - Pfizer
 
Jose Marcio Figueiredo
No Relationships to Disclose
 
Rachel Cossetti Leal
No Relationships to Disclose
 
Andréa Lopes
No Relationships to Disclose
 
Luis Werneck De Carvalho
Employment - HIAE - HOSPITAL ISRAELITA ALBERT EINSTEIN; ONCOLOGICA DO BRASIL CANCER CENTER
Leadership - ONCOLOGICA DO BRASIL CANCER CENTER
Honoraria - Amgen; Roche
Research Funding - Amgen (Inst); Roche (Inst)
 
Fernanda Schwyter
No Relationships to Disclose
 
Tainá Cabalheiro
No Relationships to Disclose
 
Carlos Barrios
Stock and Other Ownership Interests - CPO; MedSIR; Thummi
Honoraria - Adium Pharma; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Research Funding - Amgen (Inst); AstraZeneca (Inst); Aveo (Inst); BioNTech SE (Inst); BMS Brazil (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Dizal Pharma (Inst); Exelixis (Inst); Exelixis (Inst); FORTREA (Inst); FORTREA (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); ICON Clinical Research (Inst); IQvia (Inst); Janssen (Inst); LabCorp (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Novocure (Inst); Nuvisan (Inst); OBI Pharma (Inst); Parexel (Inst); Pfizer (Inst); PharmaMar (Inst); PPD Global (Inst); PSI (Inst); Regeneron (Inst); Roche/Genentech (Inst); Samsung (Inst); Sandoz (Inst); Sanofi (Inst); Servier (Inst); Sremline (Inst); Syneos Health (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TRIO US (Inst); Worldwide Clinical Trials (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BMS Brazil; Lilly; MSD Oncology; Novartis; Pfizer; Roche/Genentech
 
Latin American Cooperative Oncology Group (LACOG)
No Relationships to Disclose